Technical Analysis for RCE - Recce Ltd
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Boomer Buy Setup | Bullish Swing Setup | 1.56% | |
NR7 | Range Contraction | 1.56% | |
Wide Bands | Range Expansion | 1.56% | |
Gapped Up | Strength | 1.56% | |
Overbought Stochastic | Strength | 1.56% | |
Wide Bands | Range Expansion | 1.56% | |
Overbought Stochastic | Strength | 1.56% | |
Wide Bands | Range Expansion | -1.52% | |
Overbought Stochastic | Strength | -1.52% | |
180 Bullish Setup | Bullish Swing Setup | -1.52% |
Alert | Time |
---|---|
Possible NR7 | 29 minutes ago |
Gap Up Closed | about 3 hours ago |
Gap Up Partially Closed | about 3 hours ago |
Reversed from Up | about 3 hours ago |
Gapped Up (Partial) | about 3 hours ago |
Get a Trading Assistant
Recce Ltd Description
Recce Limited is an Australia-based research-based pharmaceutical company. The Company is principally engaged in research and development of antibiotic drugs and anticancer drugs. The Company's antibiotics kill both susceptible bacteria and drug resistant super bugs throughout the world health danger arising from resistance to present-day antibiotics. The Company offers antibiotic drugs to treat the diseases caused by Sepsis, Helicobacter Pylori (H.Pylori), Escherichia coli (E.coli), Gonorrhea and Tuberculosis (TB). The Company offers anticancer drugs to treat various cancers, such as leukemia, prostate, lung, stomach, intestine, kidney and melanoma. The Company also offers polymer-antibiotics targeted for human use. The Company's Recce antibiotic kills all types of bacteria, including superbugs. Its subsidiaries include Recce (USA) LLP and Recce (UK) Limited.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Health Medicine Pharmaceutical Disease Cancer Diseases Drugs Cancers Resistance Pharmaceuticals Policy Bacteria Bacteriology Antibiotic Chemotherapy Antibiotics Leukemia Melanoma Stomach Veterinary Medicine
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.785 |
52 Week Low | 0.41 |
Average Volume | 185,970 |
200-Day Moving Average | 0.519 |
50-Day Moving Average | 0.491 |
20-Day Moving Average | 0.559 |
10-Day Moving Average | 0.626 |
Average True Range | 0.030 |
RSI (14) | 66.22 |
ADX | 43.35 |
+DI | 36.682 |
-DI | 12.211 |
Chandelier Exit (Long, 3 ATRs) | 0.605 |
Chandelier Exit (Short, 3 ATRs) | 0.520 |
Upper Bollinger Bands | 0.717 |
Lower Bollinger Band | 0.401 |
Percent B (%b) | 0.76 |
BandWidth | 56.673 |
MACD Line | 0.051 |
MACD Signal Line | 0.043 |
MACD Histogram | 0.0083 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.670 | ||||
Resistance 3 (R3) | 0.673 | 0.667 | 0.665 | ||
Resistance 2 (R2) | 0.667 | 0.659 | 0.665 | 0.663 | |
Resistance 1 (R1) | 0.653 | 0.654 | 0.650 | 0.650 | 0.662 |
Pivot Point | 0.647 | 0.647 | 0.645 | 0.645 | 0.647 |
Support 1 (S1) | 0.633 | 0.639 | 0.630 | 0.630 | 0.618 |
Support 2 (S2) | 0.627 | 0.634 | 0.625 | 0.617 | |
Support 3 (S3) | 0.613 | 0.627 | 0.615 | ||
Support 4 (S4) | 0.610 |